PKMYT1
TYR version of PSPA with Y as phospho-acceptor
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06493 | T14 | GPS6|SIGNOR|EPSD|PSP | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | _______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKK |
| P06493 | Y15 | SIGNOR|EPSD|PSP | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q08J23 | S593 | Sugiyama | NSUN2 SAKI TRM4 | NNSEKMKVINTGIKVWCRNNsGEEFDCAFRLAQEGIYTLYP |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q99640 | S120 | Sugiyama | PKMYT1 MYT1 | sRPEsFFQQsFQRLSRLGHGsyGEVFKVRSKEDGRLYAVKR |
| Q99640 | S469 | Sugiyama | PKMYT1 MYT1 | TVGSTStPRSRCtPRDALDLsDINsEPPRGsFPsFEPRNLL |
| Q99640 | S479 | Sugiyama | PKMYT1 MYT1 | RCtPRDALDLsDINsEPPRGsFPsFEPRNLLSLFEDtLDPT |
| Q99640 | S482 | Sugiyama | PKMYT1 MYT1 | PRDALDLsDINsEPPRGsFPsFEPRNLLSLFEDtLDPT___ |
| Q99640 | Y121 | Sugiyama | PKMYT1 MYT1 | RPEsFFQQsFQRLSRLGHGsyGEVFKVRSKEDGRLYAVKRs |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.096203e-06 | 5.960 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.294484e-07 | 6.137 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.076979e-06 | 5.683 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.843149e-06 | 5.415 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.918282e-06 | 5.407 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.850172e-06 | 5.545 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.543556e-06 | 5.068 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.388997e-05 | 4.857 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.301006e-05 | 4.886 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.491212e-05 | 4.348 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.073549e-05 | 4.217 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.384341e-05 | 4.077 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.220899e-04 | 3.913 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.259950e-04 | 3.900 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.241750e-04 | 3.906 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.081783e-04 | 3.966 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.886802e-05 | 4.005 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.562232e-04 | 3.806 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.228160e-04 | 3.652 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.063671e-04 | 3.685 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.309006e-04 | 3.637 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.228160e-04 | 3.652 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.624631e-04 | 3.581 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.624631e-04 | 3.581 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.062311e-04 | 3.514 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 4.657529e-04 | 3.332 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 4.657529e-04 | 3.332 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 4.657529e-04 | 3.332 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 4.657529e-04 | 3.332 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.425257e-04 | 3.354 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.318547e-04 | 3.365 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.746065e-04 | 3.111 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.746065e-04 | 3.111 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 8.224180e-04 | 3.085 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 8.224180e-04 | 3.085 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.065262e-03 | 2.973 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.276364e-03 | 2.894 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.825583e-03 | 2.739 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.825583e-03 | 2.739 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.825583e-03 | 2.739 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.833665e-03 | 2.737 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.189974e-03 | 2.660 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.189974e-03 | 2.660 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.359607e-03 | 2.627 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.468095e-03 | 2.608 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.641559e-03 | 2.578 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.878685e-03 | 2.541 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.201952e-03 | 2.495 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.186563e-03 | 2.497 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.513901e-03 | 2.454 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.513901e-03 | 2.454 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.517120e-03 | 2.454 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.025237e-03 | 2.395 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.861073e-03 | 2.413 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.228435e-03 | 2.374 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.616326e-03 | 2.336 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.712075e-03 | 2.327 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.936060e-03 | 2.307 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.300904e-03 | 2.276 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.906310e-03 | 2.229 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 5.932560e-03 | 2.227 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 5.932560e-03 | 2.227 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.932560e-03 | 2.227 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.379373e-03 | 2.195 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.550779e-03 | 2.184 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.550779e-03 | 2.184 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.391676e-03 | 2.131 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.175294e-03 | 2.087 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.175294e-03 | 2.087 | 0 | 0 |
| Drug resistance of ALK mutants | R-HSA-9700649 | 1.025600e-02 | 1.989 | 0 | 0 |
| ceritinib-resistant ALK mutants | R-HSA-9717323 | 1.025600e-02 | 1.989 | 0 | 0 |
| crizotinib-resistant ALK mutants | R-HSA-9717326 | 1.025600e-02 | 1.989 | 0 | 0 |
| NVP-TAE684-resistant ALK mutants | R-HSA-9717301 | 1.025600e-02 | 1.989 | 0 | 0 |
| lorlatinib-resistant ALK mutants | R-HSA-9717329 | 1.025600e-02 | 1.989 | 0 | 0 |
| alectinib-resistant ALK mutants | R-HSA-9717316 | 1.025600e-02 | 1.989 | 0 | 0 |
| ASP-3026-resistant ALK mutants | R-HSA-9717264 | 1.025600e-02 | 1.989 | 0 | 0 |
| brigatinib-resistant ALK mutants | R-HSA-9717319 | 1.025600e-02 | 1.989 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.687304e-03 | 2.014 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.031883e-02 | 1.986 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.031883e-02 | 1.986 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.523075e-03 | 2.069 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.073912e-02 | 1.969 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.158858e-02 | 1.936 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.213709e-02 | 1.916 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.213709e-02 | 1.916 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.235429e-02 | 1.908 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.273586e-02 | 1.895 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.383001e-02 | 1.859 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.429964e-02 | 1.845 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.445368e-02 | 1.840 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.515667e-02 | 1.819 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.515667e-02 | 1.819 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.543132e-02 | 1.812 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.602536e-02 | 1.795 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.707016e-02 | 1.768 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.707016e-02 | 1.768 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.799874e-02 | 1.745 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.686118e-02 | 1.773 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.780374e-02 | 1.749 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.739555e-02 | 1.760 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.925200e-02 | 1.716 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.040745e-02 | 1.690 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.040745e-02 | 1.690 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.040745e-02 | 1.690 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.204458e-02 | 1.657 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.022050e-02 | 1.694 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.069891e-02 | 1.684 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.204458e-02 | 1.657 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.265976e-02 | 1.645 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.204458e-02 | 1.657 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.022050e-02 | 1.694 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.393413e-02 | 1.621 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.393413e-02 | 1.621 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.471837e-02 | 1.607 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.790361e-02 | 1.554 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.790361e-02 | 1.554 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.912835e-02 | 1.536 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.998057e-02 | 1.523 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.836843e-02 | 1.547 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.703401e-02 | 1.568 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.828207e-02 | 1.548 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.782293e-02 | 1.556 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.029164e-02 | 1.519 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.045539e-02 | 1.516 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.211708e-02 | 1.493 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.211708e-02 | 1.493 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.211708e-02 | 1.493 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.211708e-02 | 1.493 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.392658e-02 | 1.469 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.518635e-02 | 1.454 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.518635e-02 | 1.454 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.656307e-02 | 1.437 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.886976e-02 | 1.410 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.040089e-02 | 1.394 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.040089e-02 | 1.394 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.123044e-02 | 1.385 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.046386e-02 | 1.393 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.611802e-02 | 1.336 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.758955e-02 | 1.322 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.758955e-02 | 1.322 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.943263e-02 | 1.404 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.910891e-02 | 1.408 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.123044e-02 | 1.385 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.046386e-02 | 1.393 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.910891e-02 | 1.408 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.364377e-02 | 1.360 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.583288e-02 | 1.339 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.024497e-02 | 1.299 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.024497e-02 | 1.299 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.024497e-02 | 1.299 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.024497e-02 | 1.299 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.024497e-02 | 1.299 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.024497e-02 | 1.299 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.060130e-02 | 1.296 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.214124e-02 | 1.283 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.368065e-02 | 1.270 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.528853e-02 | 1.257 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.915728e-02 | 1.228 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.915728e-02 | 1.228 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.963301e-02 | 1.157 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 6.963301e-02 | 1.157 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.917898e-02 | 1.101 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.917898e-02 | 1.101 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.917898e-02 | 1.101 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.752303e-02 | 1.171 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.330425e-02 | 1.135 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.923834e-02 | 1.101 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.354277e-02 | 1.197 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.917898e-02 | 1.101 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.998867e-02 | 1.222 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.752303e-02 | 1.171 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.752303e-02 | 1.171 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.855646e-02 | 1.164 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.944529e-02 | 1.158 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.190353e-02 | 1.208 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.699541e-02 | 1.174 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.752303e-02 | 1.171 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.917898e-02 | 1.101 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.917898e-02 | 1.101 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.190353e-02 | 1.208 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.963301e-02 | 1.157 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.699541e-02 | 1.174 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 6.399504e-02 | 1.194 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.751778e-02 | 1.111 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.752303e-02 | 1.171 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.039398e-02 | 1.152 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.973290e-02 | 1.098 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 9.797983e-02 | 1.009 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 9.797983e-02 | 1.009 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 1.072367e-01 | 0.970 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.072367e-01 | 0.970 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.072367e-01 | 0.970 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.072367e-01 | 0.970 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.163991e-01 | 0.934 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.254680e-01 | 0.901 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 1.344444e-01 | 0.871 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.433293e-01 | 0.844 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.433293e-01 | 0.844 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.521234e-01 | 0.818 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.779711e-01 | 0.750 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.947663e-01 | 0.710 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.947663e-01 | 0.710 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.112203e-01 | 0.675 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.531676e-02 | 1.069 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.193215e-01 | 0.659 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.153122e-02 | 1.038 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.153122e-02 | 1.038 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.468695e-02 | 1.024 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.273400e-01 | 0.643 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.273400e-01 | 0.643 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.347131e-01 | 0.871 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.417105e-01 | 0.849 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.667612e-01 | 0.778 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.667612e-01 | 0.778 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.777213e-01 | 0.750 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.109121e-01 | 0.955 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.355259e-02 | 1.078 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.030355e-01 | 0.692 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.942657e-02 | 1.049 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.043365e-01 | 0.982 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.254680e-01 | 0.901 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.344444e-01 | 0.871 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 2.352767e-01 | 0.628 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.787371e-02 | 1.009 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.001610e-01 | 0.999 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.608279e-01 | 0.794 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.608279e-01 | 0.794 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.153122e-02 | 1.038 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.942657e-02 | 1.049 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.999505e-01 | 0.699 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 8.862760e-02 | 1.052 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 1.608279e-01 | 0.794 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.209713e-01 | 0.917 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.072367e-01 | 0.970 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.254680e-01 | 0.901 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.779711e-01 | 0.750 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.452381e-01 | 0.838 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.036884e-01 | 0.691 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.142226e-02 | 1.039 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.372757e-01 | 0.862 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.209330e-01 | 0.656 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.209330e-01 | 0.656 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.209330e-01 | 0.656 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.797983e-02 | 1.009 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.163991e-01 | 0.934 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.254680e-01 | 0.901 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.344444e-01 | 0.871 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.694435e-01 | 0.771 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.273400e-01 | 0.643 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.273400e-01 | 0.643 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.694435e-01 | 0.771 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.999505e-01 | 0.699 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.521234e-01 | 0.818 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 9.797983e-02 | 1.009 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 9.797983e-02 | 1.009 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.947663e-01 | 0.710 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.840749e-02 | 1.054 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.076107e-01 | 0.968 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.347131e-01 | 0.871 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.487839e-01 | 0.827 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.452098e-01 | 0.610 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.767279e-01 | 0.753 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.193215e-01 | 0.659 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.099595e-01 | 0.959 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.779711e-01 | 0.750 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.431323e-01 | 0.614 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.175933e-01 | 0.930 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.521234e-01 | 0.818 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.779711e-01 | 0.750 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.779711e-01 | 0.750 | 0 | 0 |
| Translation | R-HSA-72766 | 1.845392e-01 | 0.734 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.554337e-02 | 1.020 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 2.344373e-01 | 0.630 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.399000e-01 | 0.854 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.850894e-01 | 0.733 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 8.862760e-02 | 1.052 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 1.344444e-01 | 0.871 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.521234e-01 | 0.818 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.521234e-01 | 0.818 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.608279e-01 | 0.794 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.779711e-01 | 0.750 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.779711e-01 | 0.750 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.300444e-01 | 0.638 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 8.862760e-02 | 1.052 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.344444e-01 | 0.871 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 1.344444e-01 | 0.871 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.694435e-01 | 0.771 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.431323e-01 | 0.614 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.243732e-01 | 0.905 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.707030e-01 | 0.768 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.112203e-01 | 0.675 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.074341e-01 | 0.683 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 1.010905e-01 | 0.995 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.627865e-01 | 0.788 | 1 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.163991e-01 | 0.934 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.779711e-01 | 0.750 | 0 | 0 |
| Carnitine synthesis | R-HSA-71262 | 1.864118e-01 | 0.730 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.667277e-01 | 0.778 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.542590e-01 | 0.812 | 1 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.608279e-01 | 0.794 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.578339e-01 | 0.802 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.316532e-01 | 0.635 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.954699e-01 | 0.709 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.764372e-01 | 0.753 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 9.797983e-02 | 1.009 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.344444e-01 | 0.871 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.344444e-01 | 0.871 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.175933e-01 | 0.930 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.175933e-01 | 0.930 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.918544e-01 | 0.717 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.112203e-01 | 0.675 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.101908e-01 | 0.958 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.426106e-01 | 0.615 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.163991e-01 | 0.934 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.694435e-01 | 0.771 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.864118e-01 | 0.730 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.864118e-01 | 0.730 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.595235e-01 | 0.797 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.542203e-02 | 1.020 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.667612e-01 | 0.778 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.101908e-01 | 0.958 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.864118e-01 | 0.730 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.999505e-01 | 0.699 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.074341e-01 | 0.683 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.925007e-01 | 0.716 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.163991e-01 | 0.934 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.521234e-01 | 0.818 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.030355e-01 | 0.692 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.030355e-01 | 0.692 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.112203e-01 | 0.675 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.864118e-01 | 0.730 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.431323e-01 | 0.614 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.072367e-01 | 0.970 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.163991e-01 | 0.934 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.521234e-01 | 0.818 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.326121e-01 | 0.877 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.468695e-02 | 1.024 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.417550e-01 | 0.848 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.112203e-01 | 0.675 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.273400e-01 | 0.643 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.631350e-01 | 0.787 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.352767e-01 | 0.628 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.352767e-01 | 0.628 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.813996e-01 | 0.741 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.511754e-01 | 0.821 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.123620e-01 | 0.949 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.112203e-01 | 0.675 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.595235e-01 | 0.797 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.123620e-01 | 0.949 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.142400e-01 | 0.942 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.313940e-01 | 0.636 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.417105e-01 | 0.849 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.942657e-02 | 1.049 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.947663e-01 | 0.710 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 1.559273e-01 | 0.807 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.277979e-01 | 0.893 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.688653e-01 | 0.772 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.076107e-01 | 0.968 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.231164e-02 | 1.085 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.167222e-01 | 0.933 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.036310e-01 | 0.691 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.453457e-01 | 0.610 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.490082e-01 | 0.604 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.493534e-01 | 0.603 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.509077e-01 | 0.600 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 2.509077e-01 | 0.600 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.509077e-01 | 0.600 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.509077e-01 | 0.600 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.528086e-01 | 0.597 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.544597e-01 | 0.594 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.563338e-01 | 0.591 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.563338e-01 | 0.591 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.566105e-01 | 0.591 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.566105e-01 | 0.591 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.586037e-01 | 0.587 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.586037e-01 | 0.587 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.586037e-01 | 0.587 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.662211e-01 | 0.575 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.662211e-01 | 0.575 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.662211e-01 | 0.575 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.662211e-01 | 0.575 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.680209e-01 | 0.572 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.718246e-01 | 0.566 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.737608e-01 | 0.563 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.737608e-01 | 0.563 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.737608e-01 | 0.563 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.737608e-01 | 0.563 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.756278e-01 | 0.560 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.794299e-01 | 0.554 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.812234e-01 | 0.551 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 2.812234e-01 | 0.551 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.812234e-01 | 0.551 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.812234e-01 | 0.551 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.812234e-01 | 0.551 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.812234e-01 | 0.551 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.832308e-01 | 0.548 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.886097e-01 | 0.540 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.886097e-01 | 0.540 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.886097e-01 | 0.540 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.886097e-01 | 0.540 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.886097e-01 | 0.540 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.886097e-01 | 0.540 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 2.886097e-01 | 0.540 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.959207e-01 | 0.529 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.959207e-01 | 0.529 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.984138e-01 | 0.525 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.022026e-01 | 0.520 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.022026e-01 | 0.520 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.022026e-01 | 0.520 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.031569e-01 | 0.518 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.031569e-01 | 0.518 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.031569e-01 | 0.518 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 3.031569e-01 | 0.518 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.031569e-01 | 0.518 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.062513e-01 | 0.514 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.097697e-01 | 0.509 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.097697e-01 | 0.509 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.097697e-01 | 0.509 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.103192e-01 | 0.508 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.103192e-01 | 0.508 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.103192e-01 | 0.508 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.103192e-01 | 0.508 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.120607e-01 | 0.506 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.142015e-01 | 0.503 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.165449e-01 | 0.500 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.174084e-01 | 0.498 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.174084e-01 | 0.498 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.174084e-01 | 0.498 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.175935e-01 | 0.498 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.176726e-01 | 0.498 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.176726e-01 | 0.498 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.176726e-01 | 0.498 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 3.244251e-01 | 0.489 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.244251e-01 | 0.489 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.313701e-01 | 0.480 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.313701e-01 | 0.480 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.340862e-01 | 0.476 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.382441e-01 | 0.471 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.382441e-01 | 0.471 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.382441e-01 | 0.471 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.385051e-01 | 0.470 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.398507e-01 | 0.469 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.435849e-01 | 0.464 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.450479e-01 | 0.462 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.450479e-01 | 0.462 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.450479e-01 | 0.462 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.450479e-01 | 0.462 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.510331e-01 | 0.455 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.510331e-01 | 0.455 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.510331e-01 | 0.455 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.510331e-01 | 0.455 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.510331e-01 | 0.455 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.517821e-01 | 0.454 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.517821e-01 | 0.454 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.517821e-01 | 0.454 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.517821e-01 | 0.454 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.517821e-01 | 0.454 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.547466e-01 | 0.450 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.584475e-01 | 0.446 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.584475e-01 | 0.446 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.584475e-01 | 0.446 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.584475e-01 | 0.446 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.584527e-01 | 0.446 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.584527e-01 | 0.446 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.597122e-01 | 0.444 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.650448e-01 | 0.438 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.650448e-01 | 0.438 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.650448e-01 | 0.438 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 3.650448e-01 | 0.438 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.658417e-01 | 0.437 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.658417e-01 | 0.437 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.695242e-01 | 0.432 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.715747e-01 | 0.430 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.715747e-01 | 0.430 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.765417e-01 | 0.424 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.780378e-01 | 0.422 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.780378e-01 | 0.422 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.780378e-01 | 0.422 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.780378e-01 | 0.422 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.780378e-01 | 0.422 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.780378e-01 | 0.422 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.780378e-01 | 0.422 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.805207e-01 | 0.420 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.820559e-01 | 0.418 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.841686e-01 | 0.415 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.844348e-01 | 0.415 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.844348e-01 | 0.415 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.844348e-01 | 0.415 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.844348e-01 | 0.415 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.844348e-01 | 0.415 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.844348e-01 | 0.415 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.878073e-01 | 0.411 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.878073e-01 | 0.411 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.907664e-01 | 0.408 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.907664e-01 | 0.408 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.907664e-01 | 0.408 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.970333e-01 | 0.401 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.970333e-01 | 0.401 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.970333e-01 | 0.401 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.970333e-01 | 0.401 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.986665e-01 | 0.399 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.986665e-01 | 0.399 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.986836e-01 | 0.399 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.014438e-01 | 0.396 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.016681e-01 | 0.396 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.093755e-01 | 0.388 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.093755e-01 | 0.388 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.093755e-01 | 0.388 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.093755e-01 | 0.388 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.094366e-01 | 0.388 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.094366e-01 | 0.388 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.154521e-01 | 0.381 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.154521e-01 | 0.381 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.154521e-01 | 0.381 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.154521e-01 | 0.381 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.165647e-01 | 0.380 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.214666e-01 | 0.375 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.214666e-01 | 0.375 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.214666e-01 | 0.375 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.214666e-01 | 0.375 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.214666e-01 | 0.375 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.214666e-01 | 0.375 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.214666e-01 | 0.375 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.274195e-01 | 0.369 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.274195e-01 | 0.369 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.274195e-01 | 0.369 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.333115e-01 | 0.363 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.333115e-01 | 0.363 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.341942e-01 | 0.362 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 4.391433e-01 | 0.357 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.500836e-01 | 0.347 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.506285e-01 | 0.346 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.506285e-01 | 0.346 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.515370e-01 | 0.345 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.562831e-01 | 0.341 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.562831e-01 | 0.341 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.562831e-01 | 0.341 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.564472e-01 | 0.341 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.618799e-01 | 0.335 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.618799e-01 | 0.335 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.618799e-01 | 0.335 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.618799e-01 | 0.335 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.655925e-01 | 0.332 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.674194e-01 | 0.330 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.674194e-01 | 0.330 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.674194e-01 | 0.330 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.674194e-01 | 0.330 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.690625e-01 | 0.329 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.717011e-01 | 0.326 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.719475e-01 | 0.326 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.729022e-01 | 0.325 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.753053e-01 | 0.323 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.753053e-01 | 0.323 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.783289e-01 | 0.320 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.786502e-01 | 0.320 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.837001e-01 | 0.315 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.837001e-01 | 0.315 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.837001e-01 | 0.315 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.837001e-01 | 0.315 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.851655e-01 | 0.314 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.853011e-01 | 0.314 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.890162e-01 | 0.311 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.890162e-01 | 0.311 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.918996e-01 | 0.308 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.951762e-01 | 0.305 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.951790e-01 | 0.305 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.994860e-01 | 0.301 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.994860e-01 | 0.301 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.994860e-01 | 0.301 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 4.994860e-01 | 0.301 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.046406e-01 | 0.297 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.046406e-01 | 0.297 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.080528e-01 | 0.294 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.097424e-01 | 0.293 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.097424e-01 | 0.293 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.113744e-01 | 0.291 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.113744e-01 | 0.291 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.147920e-01 | 0.288 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.147920e-01 | 0.288 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.147920e-01 | 0.288 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.147920e-01 | 0.288 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.147920e-01 | 0.288 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.147920e-01 | 0.288 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.177573e-01 | 0.286 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.197899e-01 | 0.284 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.197899e-01 | 0.284 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.247367e-01 | 0.280 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.247367e-01 | 0.280 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.247367e-01 | 0.280 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.296327e-01 | 0.276 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.303572e-01 | 0.275 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.303572e-01 | 0.275 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.396605e-01 | 0.268 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.405155e-01 | 0.267 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.440222e-01 | 0.264 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.440222e-01 | 0.264 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.441391e-01 | 0.264 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.457921e-01 | 0.263 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.478458e-01 | 0.261 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.488367e-01 | 0.261 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.491899e-01 | 0.260 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.533712e-01 | 0.257 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.533712e-01 | 0.257 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.533712e-01 | 0.257 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.579740e-01 | 0.253 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.579740e-01 | 0.253 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.579740e-01 | 0.253 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.579740e-01 | 0.253 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.579740e-01 | 0.253 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.579740e-01 | 0.253 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.579740e-01 | 0.253 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.608726e-01 | 0.251 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.670387e-01 | 0.246 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.670387e-01 | 0.246 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.670387e-01 | 0.246 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.715014e-01 | 0.243 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 5.715014e-01 | 0.243 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.759185e-01 | 0.240 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.759185e-01 | 0.240 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.802903e-01 | 0.236 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.834730e-01 | 0.234 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.871136e-01 | 0.231 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.889000e-01 | 0.230 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.889000e-01 | 0.230 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 5.889000e-01 | 0.230 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.889000e-01 | 0.230 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.889000e-01 | 0.230 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.889000e-01 | 0.230 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.931387e-01 | 0.227 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.956008e-01 | 0.225 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.973340e-01 | 0.224 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.973340e-01 | 0.224 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.007958e-01 | 0.221 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.017154e-01 | 0.221 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.017154e-01 | 0.221 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.039578e-01 | 0.219 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.096637e-01 | 0.215 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.136897e-01 | 0.212 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.136897e-01 | 0.212 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.176743e-01 | 0.209 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.176743e-01 | 0.209 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.216181e-01 | 0.206 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.216181e-01 | 0.206 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.293848e-01 | 0.201 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.323902e-01 | 0.199 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.332085e-01 | 0.198 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.332085e-01 | 0.198 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.386693e-01 | 0.195 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.425163e-01 | 0.192 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.444459e-01 | 0.191 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.481152e-01 | 0.188 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.553411e-01 | 0.184 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.553411e-01 | 0.184 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.588986e-01 | 0.181 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.612816e-01 | 0.180 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.624195e-01 | 0.179 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.659044e-01 | 0.177 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.659044e-01 | 0.177 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.693534e-01 | 0.174 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.727671e-01 | 0.172 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.727671e-01 | 0.172 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.761458e-01 | 0.170 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.780784e-01 | 0.169 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.794897e-01 | 0.168 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.794897e-01 | 0.168 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.827994e-01 | 0.166 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.827994e-01 | 0.166 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.827994e-01 | 0.166 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.860750e-01 | 0.164 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.925259e-01 | 0.160 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.941953e-01 | 0.159 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.957017e-01 | 0.158 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.957017e-01 | 0.158 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.957017e-01 | 0.158 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.988449e-01 | 0.156 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.008975e-01 | 0.154 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.019558e-01 | 0.154 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.031045e-01 | 0.153 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.050348e-01 | 0.152 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.080822e-01 | 0.150 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.080822e-01 | 0.150 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.113511e-01 | 0.148 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.140834e-01 | 0.146 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.140834e-01 | 0.146 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.214409e-01 | 0.142 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.228560e-01 | 0.141 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.285553e-01 | 0.138 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.313610e-01 | 0.136 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.350974e-01 | 0.134 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.368864e-01 | 0.133 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.386001e-01 | 0.132 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.396066e-01 | 0.131 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.406761e-01 | 0.130 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.422988e-01 | 0.129 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.444769e-01 | 0.128 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.527938e-01 | 0.123 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.527938e-01 | 0.123 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.527938e-01 | 0.123 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.577281e-01 | 0.120 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.603852e-01 | 0.119 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.668705e-01 | 0.115 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.677449e-01 | 0.115 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.701478e-01 | 0.113 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.701478e-01 | 0.113 | 1 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.817969e-01 | 0.107 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.862904e-01 | 0.104 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.887428e-01 | 0.103 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.950035e-01 | 0.100 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 7.971260e-01 | 0.098 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.988575e-01 | 0.098 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.013057e-01 | 0.096 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.053998e-01 | 0.094 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.094100e-01 | 0.092 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.113842e-01 | 0.091 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.198933e-01 | 0.086 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.246460e-01 | 0.084 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.264633e-01 | 0.083 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.282619e-01 | 0.082 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.300419e-01 | 0.081 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.300419e-01 | 0.081 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.335472e-01 | 0.079 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.335472e-01 | 0.079 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.352728e-01 | 0.078 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.369806e-01 | 0.077 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.369806e-01 | 0.077 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.376485e-01 | 0.077 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.386708e-01 | 0.076 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.419991e-01 | 0.075 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.484524e-01 | 0.071 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.531197e-01 | 0.069 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.591214e-01 | 0.066 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.634621e-01 | 0.064 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.634621e-01 | 0.064 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.717486e-01 | 0.060 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.769932e-01 | 0.057 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.782707e-01 | 0.056 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.788842e-01 | 0.056 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.832502e-01 | 0.054 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.080084e-01 | 0.042 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.155645e-01 | 0.038 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.181740e-01 | 0.037 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.255311e-01 | 0.034 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.265972e-01 | 0.033 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.270746e-01 | 0.033 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.329368e-01 | 0.030 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.376805e-01 | 0.028 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.396099e-01 | 0.027 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.468403e-01 | 0.024 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.478576e-01 | 0.023 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.549848e-01 | 0.020 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.623593e-01 | 0.017 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.635184e-01 | 0.016 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.653490e-01 | 0.015 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.722522e-01 | 0.012 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.810176e-01 | 0.008 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.885732e-01 | 0.005 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.885732e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.895786e-01 | 0.005 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.932026e-01 | 0.003 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.940183e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.949057e-01 | 0.002 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.960842e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.966701e-01 | 0.001 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999999e-01 | 0.000 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.000000e+00 | 0.000 | 1 | 1 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.000000e+00 | 0.000 | 1 | 1 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.298961e-14 | 13.886 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.993606e-14 | 13.097 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.325252e-13 | 12.135 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.048839e-11 | 10.688 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.712053e-11 | 10.430 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.445029e-10 | 9.352 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.128443e-09 | 8.948 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.198329e-09 | 8.658 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.046032e-09 | 8.297 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.037378e-08 | 7.691 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.136652e-07 | 6.944 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.354086e-07 | 6.868 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.393156e-07 | 6.621 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.844318e-07 | 6.165 | 1 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.844995e-07 | 6.105 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 8.016395e-07 | 6.096 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.991893e-06 | 5.524 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.532776e-05 | 4.815 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.144662e-05 | 4.669 | 1 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.657642e-05 | 4.576 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.554100e-05 | 4.593 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.073881e-05 | 4.390 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.721638e-05 | 4.326 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.645291e-05 | 4.248 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.214030e-05 | 4.207 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.479122e-05 | 4.188 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.479122e-05 | 4.188 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.957511e-05 | 4.158 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.638029e-05 | 4.117 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.373645e-05 | 4.077 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.167858e-05 | 4.038 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.040742e-05 | 4.044 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.283628e-05 | 4.032 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.127350e-04 | 3.948 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.305249e-04 | 3.884 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.394633e-04 | 3.856 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.573471e-04 | 3.803 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.698481e-04 | 3.770 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.924579e-04 | 3.716 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.925013e-04 | 3.716 | 1 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.121544e-04 | 3.673 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.363707e-04 | 3.626 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.614084e-04 | 3.583 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.659612e-04 | 3.575 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.746429e-04 | 3.561 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.879567e-04 | 3.541 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.879567e-04 | 3.541 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.163748e-04 | 3.500 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.513270e-04 | 3.454 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.814990e-04 | 3.419 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.705336e-04 | 3.431 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.270986e-04 | 3.369 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.457406e-04 | 3.351 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.352908e-04 | 3.271 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.886344e-04 | 3.230 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.315540e-04 | 3.200 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.788282e-04 | 3.168 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.068421e-04 | 3.151 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.933921e-04 | 3.101 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.814022e-04 | 3.055 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.502498e-04 | 3.022 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.502498e-04 | 3.022 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.379426e-04 | 3.028 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.177495e-04 | 3.037 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.524867e-04 | 3.021 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.032684e-03 | 2.986 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.048583e-03 | 2.979 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.152547e-03 | 2.938 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.131125e-03 | 2.946 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.165135e-03 | 2.934 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.203008e-03 | 2.920 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.207629e-03 | 2.918 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.312396e-03 | 2.882 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.315036e-03 | 2.881 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.386022e-03 | 2.858 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.485025e-03 | 2.828 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.622891e-03 | 2.790 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.618702e-03 | 2.791 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.997886e-03 | 2.699 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.025545e-03 | 2.693 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.118020e-03 | 2.674 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.191330e-03 | 2.659 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.197718e-03 | 2.658 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.302977e-03 | 2.638 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.344005e-03 | 2.630 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.508863e-03 | 2.601 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 2.882488e-03 | 2.540 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.826371e-03 | 2.549 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.984112e-03 | 2.525 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.155196e-03 | 2.501 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.338624e-03 | 2.476 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.713156e-03 | 2.430 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.440469e-03 | 2.463 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.654465e-03 | 2.437 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.729479e-03 | 2.428 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.544219e-03 | 2.450 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.447959e-03 | 2.462 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.753467e-03 | 2.426 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.991177e-03 | 2.399 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.122537e-03 | 2.385 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.182640e-03 | 2.379 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.241086e-03 | 2.373 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.285050e-03 | 2.368 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.732338e-03 | 2.325 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.127627e-03 | 2.290 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 6.055142e-03 | 2.218 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.013650e-03 | 2.221 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.234213e-03 | 2.205 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.459402e-03 | 2.190 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.134940e-03 | 2.147 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.812908e-03 | 2.167 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.564409e-03 | 2.121 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.564409e-03 | 2.121 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.898363e-03 | 2.161 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.497942e-03 | 2.125 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.497942e-03 | 2.125 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 7.526772e-03 | 2.123 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.898363e-03 | 2.161 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.763912e-03 | 2.170 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.185293e-03 | 2.144 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.076583e-03 | 2.150 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.855524e-03 | 2.105 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.194130e-03 | 2.086 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.410994e-03 | 2.075 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.410994e-03 | 2.075 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.622329e-03 | 2.064 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.129559e-03 | 2.040 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.129559e-03 | 2.040 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.678881e-03 | 2.014 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.029907e-02 | 1.987 | 1 | 1 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.072493e-02 | 1.970 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.015459e-02 | 1.993 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.029907e-02 | 1.987 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.762638e-03 | 2.010 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.029907e-02 | 1.987 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.111888e-02 | 1.954 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.112881e-02 | 1.954 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.130163e-02 | 1.947 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.183153e-02 | 1.927 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.214124e-02 | 1.916 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.301182e-02 | 1.886 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.318746e-02 | 1.880 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.327159e-02 | 1.877 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.360304e-02 | 1.866 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.365981e-02 | 1.865 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.623997e-02 | 1.789 | 1 | 1 |
| Adherens junctions interactions | R-HSA-418990 | 1.457635e-02 | 1.836 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.564616e-02 | 1.806 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.629204e-02 | 1.788 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.537280e-02 | 1.813 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.501868e-02 | 1.823 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.623997e-02 | 1.789 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.592712e-02 | 1.798 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.623997e-02 | 1.789 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.658179e-02 | 1.780 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.700733e-02 | 1.769 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.713532e-02 | 1.766 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.759630e-02 | 1.755 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.812578e-02 | 1.742 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.860236e-02 | 1.730 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.891168e-02 | 1.723 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.895757e-02 | 1.722 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.910972e-02 | 1.719 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.910972e-02 | 1.719 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.977212e-02 | 1.704 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.977212e-02 | 1.704 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.023679e-02 | 1.694 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.039539e-02 | 1.690 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.039539e-02 | 1.690 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.359405e-02 | 1.627 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.495814e-02 | 1.603 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.160844e-02 | 1.665 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.254496e-02 | 1.647 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.178320e-02 | 1.662 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.350844e-02 | 1.629 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.475296e-02 | 1.606 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.324310e-02 | 1.634 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.359405e-02 | 1.627 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.449918e-02 | 1.611 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.495814e-02 | 1.603 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.359405e-02 | 1.627 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.179074e-02 | 1.662 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.495814e-02 | 1.603 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.274775e-02 | 1.643 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.557110e-02 | 1.592 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.632073e-02 | 1.580 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.656356e-02 | 1.576 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.740859e-02 | 1.562 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.740859e-02 | 1.562 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.763774e-02 | 1.558 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.769201e-02 | 1.558 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.769201e-02 | 1.558 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.794680e-02 | 1.554 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.794680e-02 | 1.554 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.840088e-02 | 1.547 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.848032e-02 | 1.545 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.874026e-02 | 1.542 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.933389e-02 | 1.533 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.963150e-02 | 1.528 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.963150e-02 | 1.528 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.205270e-02 | 1.494 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.503995e-02 | 1.455 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.120634e-02 | 1.506 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.324997e-02 | 1.478 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.596367e-02 | 1.444 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.458488e-02 | 1.461 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.575014e-02 | 1.447 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.048763e-02 | 1.516 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.317786e-02 | 1.479 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.722903e-02 | 1.429 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.325003e-02 | 1.478 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.227097e-02 | 1.491 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.306115e-02 | 1.481 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.421630e-02 | 1.466 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.120634e-02 | 1.506 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.468626e-02 | 1.460 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.262858e-02 | 1.486 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.032996e-02 | 1.518 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.503995e-02 | 1.455 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.503995e-02 | 1.455 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.468626e-02 | 1.460 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.727094e-02 | 1.429 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.827169e-02 | 1.417 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.860825e-02 | 1.413 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.894267e-02 | 1.410 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.894267e-02 | 1.410 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.933377e-02 | 1.405 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.001832e-02 | 1.398 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.001832e-02 | 1.398 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.098345e-02 | 1.387 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.098345e-02 | 1.387 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.098345e-02 | 1.387 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.151120e-02 | 1.382 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.151120e-02 | 1.382 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.151120e-02 | 1.382 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 4.182765e-02 | 1.379 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.200584e-02 | 1.377 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.200584e-02 | 1.377 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.288735e-02 | 1.368 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.288735e-02 | 1.368 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.308387e-02 | 1.366 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.308387e-02 | 1.366 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.308387e-02 | 1.366 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.426110e-02 | 1.354 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.736120e-02 | 1.241 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.535407e-02 | 1.257 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.535407e-02 | 1.257 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.524391e-02 | 1.344 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.974250e-02 | 1.303 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.545727e-02 | 1.342 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.679999e-02 | 1.246 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.202000e-02 | 1.284 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.202000e-02 | 1.284 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.187162e-02 | 1.285 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.736120e-02 | 1.241 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.788146e-02 | 1.237 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.658453e-02 | 1.332 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.746349e-02 | 1.324 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.974250e-02 | 1.303 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.585660e-02 | 1.339 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.871219e-02 | 1.231 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.892496e-02 | 1.310 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.871219e-02 | 1.231 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.447815e-02 | 1.264 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.285399e-02 | 1.277 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.209121e-02 | 1.283 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.790383e-02 | 1.320 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.892496e-02 | 1.310 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.209121e-02 | 1.283 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.535407e-02 | 1.257 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.871219e-02 | 1.231 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.871219e-02 | 1.231 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.285399e-02 | 1.277 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.871219e-02 | 1.231 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.944919e-02 | 1.226 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.208078e-02 | 1.283 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.209121e-02 | 1.283 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.202230e-02 | 1.207 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 6.208261e-02 | 1.207 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.216411e-02 | 1.206 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.216411e-02 | 1.206 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.304241e-02 | 1.200 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.304241e-02 | 1.200 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.304241e-02 | 1.200 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.570834e-02 | 1.182 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.734201e-02 | 1.172 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.890476e-02 | 1.162 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.890476e-02 | 1.162 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.890476e-02 | 1.162 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.890476e-02 | 1.162 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.934331e-02 | 1.159 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.934331e-02 | 1.159 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.934331e-02 | 1.159 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.934331e-02 | 1.159 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.934331e-02 | 1.159 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.959572e-02 | 1.157 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.072780e-02 | 1.150 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.191062e-02 | 1.087 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.191062e-02 | 1.087 | 0 | 0 |
| Defective ADA disrupts (deoxy)adenosine deamination | R-HSA-9734735 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.191062e-02 | 1.087 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.191062e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.191062e-02 | 1.087 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.013206e-01 | 0.994 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.113264e-02 | 1.091 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.113264e-02 | 1.091 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.747889e-02 | 1.058 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.396774e-02 | 1.027 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.073382e-01 | 0.969 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.073382e-01 | 0.969 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.493810e-02 | 1.125 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.882087e-02 | 1.051 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.014856e-01 | 0.994 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.073382e-01 | 0.969 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.073382e-01 | 0.969 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.191062e-02 | 1.087 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.434666e-02 | 1.025 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.306740e-02 | 1.136 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.665564e-02 | 1.115 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.882087e-02 | 1.051 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.882087e-02 | 1.051 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.289043e-02 | 1.137 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.396774e-02 | 1.027 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.687895e-02 | 1.114 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.023900e-01 | 0.990 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.296462e-02 | 1.032 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.005904e-01 | 0.997 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.058591e-01 | 0.975 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.001361e-01 | 0.999 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.882087e-02 | 1.051 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.882087e-02 | 1.051 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.773746e-02 | 1.057 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.002025e-01 | 0.999 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.715960e-02 | 1.113 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.160217e-02 | 1.038 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.026213e-01 | 0.989 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.643157e-02 | 1.063 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.143604e-02 | 1.089 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.879726e-02 | 1.103 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.014856e-01 | 0.994 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.604437e-02 | 1.065 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.687895e-02 | 1.114 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.058591e-01 | 0.975 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.025258e-01 | 0.989 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.493810e-02 | 1.125 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.077622e-02 | 1.093 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.475746e-02 | 1.072 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.058591e-01 | 0.975 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.086985e-02 | 1.042 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.840232e-02 | 1.007 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.113264e-02 | 1.091 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.747889e-02 | 1.058 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.058591e-01 | 0.975 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.058591e-01 | 0.975 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.005904e-01 | 0.997 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.113264e-02 | 1.091 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.687895e-02 | 1.114 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.493810e-02 | 1.125 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.485267e-02 | 1.126 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.080111e-01 | 0.967 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.103052e-01 | 0.957 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.103052e-01 | 0.957 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.103052e-01 | 0.957 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.103052e-01 | 0.957 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.142032e-01 | 0.942 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.142032e-01 | 0.942 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.142032e-01 | 0.942 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.142032e-01 | 0.942 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 1.142032e-01 | 0.942 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.142032e-01 | 0.942 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.142409e-01 | 0.942 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.142409e-01 | 0.942 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.148222e-01 | 0.940 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.148222e-01 | 0.940 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.194079e-01 | 0.923 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.194079e-01 | 0.923 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.196940e-01 | 0.922 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.203215e-01 | 0.920 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.203215e-01 | 0.920 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.203215e-01 | 0.920 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.203215e-01 | 0.920 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.203215e-01 | 0.920 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.211772e-01 | 0.917 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.211772e-01 | 0.917 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.389217e-01 | 0.857 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.389217e-01 | 0.857 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.389217e-01 | 0.857 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.389217e-01 | 0.857 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.389217e-01 | 0.857 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.389217e-01 | 0.857 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.571298e-01 | 0.804 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.571298e-01 | 0.804 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.749539e-01 | 0.757 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.749539e-01 | 0.757 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.749539e-01 | 0.757 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.924022e-01 | 0.716 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.924022e-01 | 0.716 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.924022e-01 | 0.716 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.924022e-01 | 0.716 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.924022e-01 | 0.716 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.094826e-01 | 0.679 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.094826e-01 | 0.679 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.262027e-01 | 0.646 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.425702e-01 | 0.615 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.425702e-01 | 0.615 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.425702e-01 | 0.615 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.425702e-01 | 0.615 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.426789e-01 | 0.846 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.574259e-01 | 0.803 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.108515e-01 | 0.676 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.264527e-01 | 0.645 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.421329e-01 | 0.616 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.059636e-01 | 0.686 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.500157e-01 | 0.824 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.336879e-01 | 0.631 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.790776e-01 | 0.747 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.186400e-01 | 0.660 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.571298e-01 | 0.804 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.262027e-01 | 0.646 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.094826e-01 | 0.679 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.425702e-01 | 0.615 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.724419e-01 | 0.763 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.342851e-01 | 0.630 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.342851e-01 | 0.630 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.389217e-01 | 0.857 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.389217e-01 | 0.857 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.571298e-01 | 0.804 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.262027e-01 | 0.646 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.800356e-01 | 0.745 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.421329e-01 | 0.616 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.843765e-01 | 0.734 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.389217e-01 | 0.857 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.354223e-01 | 0.868 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.354223e-01 | 0.868 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.262027e-01 | 0.646 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.574259e-01 | 0.803 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 2.421329e-01 | 0.616 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 1.389217e-01 | 0.857 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.389217e-01 | 0.857 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 1.571298e-01 | 0.804 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 1.571298e-01 | 0.804 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 1.571298e-01 | 0.804 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 1.571298e-01 | 0.804 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 1.571298e-01 | 0.804 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.924022e-01 | 0.716 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.094826e-01 | 0.679 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.262027e-01 | 0.646 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.649034e-01 | 0.783 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.724419e-01 | 0.763 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.876788e-01 | 0.727 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.972857e-01 | 0.705 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.169656e-01 | 0.664 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.262027e-01 | 0.646 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.227043e-01 | 0.911 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.661771e-01 | 0.779 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.227043e-01 | 0.911 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.924022e-01 | 0.716 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.094826e-01 | 0.679 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.953659e-01 | 0.709 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.303211e-01 | 0.638 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.950955e-01 | 0.710 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.327919e-01 | 0.633 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.389217e-01 | 0.857 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.561539e-01 | 0.806 | 0 | 0 |
| Translation | R-HSA-72766 | 1.703052e-01 | 0.769 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.389217e-01 | 0.857 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 1.571298e-01 | 0.804 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.749539e-01 | 0.757 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.094826e-01 | 0.679 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.094826e-01 | 0.679 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 2.094826e-01 | 0.679 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.262027e-01 | 0.646 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.425702e-01 | 0.615 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.425702e-01 | 0.615 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.426789e-01 | 0.846 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.425702e-01 | 0.615 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.323875e-01 | 0.878 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.500157e-01 | 0.824 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.030919e-01 | 0.692 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.532671e-01 | 0.815 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.583314e-01 | 0.800 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.225123e-01 | 0.653 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.347680e-01 | 0.629 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.350918e-01 | 0.869 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.389217e-01 | 0.857 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 1.571298e-01 | 0.804 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 1.571298e-01 | 0.804 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.749539e-01 | 0.757 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.924022e-01 | 0.716 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 2.262027e-01 | 0.646 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.425702e-01 | 0.615 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.425702e-01 | 0.615 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.383990e-01 | 0.859 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.030919e-01 | 0.692 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.240604e-01 | 0.906 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.232472e-01 | 0.651 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.571298e-01 | 0.804 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 1.749539e-01 | 0.757 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.924022e-01 | 0.716 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.262027e-01 | 0.646 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.262027e-01 | 0.646 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.287778e-01 | 0.890 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.266532e-01 | 0.645 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.310457e-01 | 0.636 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.403984e-01 | 0.853 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.227043e-01 | 0.911 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.376410e-01 | 0.624 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.425702e-01 | 0.615 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.425702e-01 | 0.615 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.030919e-01 | 0.692 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.482556e-01 | 0.829 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 2.425702e-01 | 0.615 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.094826e-01 | 0.679 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.425702e-01 | 0.615 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.953659e-01 | 0.709 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.319438e-01 | 0.880 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.414872e-01 | 0.849 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.447502e-01 | 0.839 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.924022e-01 | 0.716 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 2.425702e-01 | 0.615 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.876788e-01 | 0.727 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.240604e-01 | 0.906 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.513221e-01 | 0.820 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.527948e-01 | 0.816 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.843765e-01 | 0.734 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.094826e-01 | 0.679 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 2.425702e-01 | 0.615 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.425702e-01 | 0.615 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.335580e-01 | 0.874 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.048798e-01 | 0.689 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.583314e-01 | 0.800 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.186400e-01 | 0.660 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.016310e-01 | 0.695 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.636590e-01 | 0.786 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.583314e-01 | 0.800 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.342851e-01 | 0.630 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.966517e-01 | 0.706 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.016310e-01 | 0.695 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.389217e-01 | 0.857 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 1.790776e-01 | 0.747 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.393134e-01 | 0.621 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.282527e-01 | 0.892 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.282527e-01 | 0.892 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.383990e-01 | 0.859 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.336879e-01 | 0.631 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.738217e-01 | 0.760 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.428515e-01 | 0.615 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.449615e-01 | 0.611 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.499919e-01 | 0.602 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.499919e-01 | 0.602 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.499919e-01 | 0.602 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.557245e-01 | 0.592 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.557245e-01 | 0.592 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.578582e-01 | 0.589 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.585924e-01 | 0.587 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.585924e-01 | 0.587 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.585924e-01 | 0.587 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.585924e-01 | 0.587 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.585924e-01 | 0.587 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 2.588443e-01 | 0.587 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.603665e-01 | 0.584 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.620256e-01 | 0.582 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.657280e-01 | 0.576 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.657280e-01 | 0.576 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.677480e-01 | 0.572 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.735976e-01 | 0.563 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 2.735976e-01 | 0.563 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.742767e-01 | 0.562 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.742767e-01 | 0.562 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.742767e-01 | 0.562 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.742767e-01 | 0.562 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 2.742767e-01 | 0.562 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.742767e-01 | 0.562 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.742767e-01 | 0.562 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.742767e-01 | 0.562 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.742767e-01 | 0.562 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.742767e-01 | 0.562 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.787807e-01 | 0.555 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.792345e-01 | 0.554 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.814635e-01 | 0.551 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 2.814635e-01 | 0.551 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.828508e-01 | 0.548 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.849954e-01 | 0.545 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.893224e-01 | 0.539 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.893224e-01 | 0.539 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.896302e-01 | 0.538 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.896302e-01 | 0.538 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.896302e-01 | 0.538 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.896302e-01 | 0.538 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.896302e-01 | 0.538 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.896302e-01 | 0.538 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.896302e-01 | 0.538 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.896302e-01 | 0.538 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.941206e-01 | 0.531 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.971711e-01 | 0.527 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.980171e-01 | 0.526 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.046597e-01 | 0.516 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.046597e-01 | 0.516 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.046597e-01 | 0.516 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.046597e-01 | 0.516 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.046597e-01 | 0.516 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 3.046597e-01 | 0.516 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.046597e-01 | 0.516 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 3.046597e-01 | 0.516 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.046597e-01 | 0.516 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.046597e-01 | 0.516 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.050065e-01 | 0.516 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.123144e-01 | 0.505 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.125455e-01 | 0.505 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.128256e-01 | 0.505 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.134813e-01 | 0.504 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.139176e-01 | 0.503 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.139176e-01 | 0.503 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.193722e-01 | 0.496 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.193722e-01 | 0.496 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.193722e-01 | 0.496 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.193722e-01 | 0.496 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.193722e-01 | 0.496 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.193722e-01 | 0.496 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.193722e-01 | 0.496 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 3.193722e-01 | 0.496 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.193722e-01 | 0.496 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.193722e-01 | 0.496 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.193722e-01 | 0.496 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.193944e-01 | 0.496 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.197154e-01 | 0.495 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.206257e-01 | 0.494 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.240926e-01 | 0.489 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.274200e-01 | 0.485 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.284040e-01 | 0.484 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.284040e-01 | 0.484 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.337743e-01 | 0.477 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.337743e-01 | 0.477 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.337743e-01 | 0.477 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.337743e-01 | 0.477 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.337743e-01 | 0.477 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.337743e-01 | 0.477 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.386381e-01 | 0.470 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.429052e-01 | 0.465 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.478725e-01 | 0.459 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 3.478725e-01 | 0.459 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 3.478725e-01 | 0.459 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.478725e-01 | 0.459 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.478725e-01 | 0.459 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.478725e-01 | 0.459 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 3.478725e-01 | 0.459 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.478725e-01 | 0.459 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.478725e-01 | 0.459 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.478725e-01 | 0.459 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 3.478725e-01 | 0.459 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.478725e-01 | 0.459 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 3.478725e-01 | 0.459 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.486959e-01 | 0.458 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.539195e-01 | 0.451 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.561494e-01 | 0.448 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.572526e-01 | 0.447 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.616732e-01 | 0.442 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.616732e-01 | 0.442 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.616732e-01 | 0.442 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.634008e-01 | 0.440 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.637989e-01 | 0.439 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.651047e-01 | 0.438 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.668841e-01 | 0.435 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.668841e-01 | 0.435 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.717949e-01 | 0.430 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 3.744822e-01 | 0.427 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.744822e-01 | 0.427 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.744822e-01 | 0.427 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.751826e-01 | 0.426 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 3.751826e-01 | 0.426 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.751826e-01 | 0.426 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.884070e-01 | 0.411 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.884070e-01 | 0.411 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.884070e-01 | 0.411 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.884070e-01 | 0.411 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.884070e-01 | 0.411 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.884070e-01 | 0.411 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.884070e-01 | 0.411 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.884070e-01 | 0.411 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.884070e-01 | 0.411 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.884070e-01 | 0.411 | 1 | 1 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.890203e-01 | 0.410 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.890980e-01 | 0.410 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.911201e-01 | 0.408 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.970455e-01 | 0.401 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.970455e-01 | 0.401 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.013523e-01 | 0.396 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.013523e-01 | 0.396 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.013523e-01 | 0.396 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.013523e-01 | 0.396 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.013523e-01 | 0.396 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.013523e-01 | 0.396 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.044838e-01 | 0.393 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.044838e-01 | 0.393 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.118015e-01 | 0.385 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.118015e-01 | 0.385 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.118015e-01 | 0.385 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.118781e-01 | 0.385 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.140243e-01 | 0.383 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.140243e-01 | 0.383 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.140243e-01 | 0.383 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.140243e-01 | 0.383 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.177193e-01 | 0.379 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.230949e-01 | 0.374 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.264289e-01 | 0.370 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.264289e-01 | 0.370 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.264289e-01 | 0.370 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.337823e-01 | 0.363 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.366341e-01 | 0.360 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.385716e-01 | 0.358 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.385716e-01 | 0.358 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.385716e-01 | 0.358 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.385716e-01 | 0.358 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.385716e-01 | 0.358 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 4.385716e-01 | 0.358 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.385716e-01 | 0.358 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.385716e-01 | 0.358 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.385716e-01 | 0.358 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.409866e-01 | 0.356 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.409866e-01 | 0.356 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.409866e-01 | 0.356 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.454519e-01 | 0.351 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.504580e-01 | 0.346 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.504580e-01 | 0.346 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.504580e-01 | 0.346 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.504580e-01 | 0.346 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.504580e-01 | 0.346 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 4.504580e-01 | 0.346 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.507068e-01 | 0.346 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.552423e-01 | 0.342 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.552423e-01 | 0.342 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.565025e-01 | 0.341 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 4.620934e-01 | 0.335 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 4.620934e-01 | 0.335 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 4.692873e-01 | 0.329 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.700691e-01 | 0.328 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.729019e-01 | 0.325 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 4.734832e-01 | 0.325 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.734832e-01 | 0.325 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.734832e-01 | 0.325 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.734832e-01 | 0.325 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 4.734832e-01 | 0.325 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.734832e-01 | 0.325 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.734832e-01 | 0.325 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.739030e-01 | 0.324 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.811239e-01 | 0.318 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.830797e-01 | 0.316 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.831144e-01 | 0.316 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.846325e-01 | 0.315 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.846325e-01 | 0.315 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.846325e-01 | 0.315 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.846325e-01 | 0.315 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.846325e-01 | 0.315 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.902265e-01 | 0.310 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.944102e-01 | 0.306 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.955464e-01 | 0.305 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.955464e-01 | 0.305 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.955464e-01 | 0.305 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.967172e-01 | 0.304 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.034327e-01 | 0.298 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.062298e-01 | 0.296 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.062298e-01 | 0.296 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.062298e-01 | 0.296 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.100901e-01 | 0.292 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.100901e-01 | 0.292 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.102071e-01 | 0.292 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.146751e-01 | 0.288 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.166877e-01 | 0.287 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.166877e-01 | 0.287 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.166877e-01 | 0.287 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.166877e-01 | 0.287 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.166877e-01 | 0.287 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.166877e-01 | 0.287 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.166889e-01 | 0.287 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.232286e-01 | 0.281 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 5.232286e-01 | 0.281 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.232286e-01 | 0.281 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.269246e-01 | 0.278 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.269246e-01 | 0.278 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.269246e-01 | 0.278 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.269246e-01 | 0.278 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.279431e-01 | 0.277 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.297088e-01 | 0.276 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.297088e-01 | 0.276 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.309629e-01 | 0.275 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.360638e-01 | 0.271 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.369453e-01 | 0.270 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.369453e-01 | 0.270 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.369453e-01 | 0.270 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.369453e-01 | 0.270 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.369453e-01 | 0.270 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.369453e-01 | 0.270 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.411332e-01 | 0.267 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.411332e-01 | 0.267 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.424887e-01 | 0.266 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.467544e-01 | 0.262 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.467544e-01 | 0.262 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.467544e-01 | 0.262 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.467544e-01 | 0.262 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 5.467544e-01 | 0.262 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.487878e-01 | 0.261 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.487878e-01 | 0.261 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.529980e-01 | 0.257 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.561484e-01 | 0.255 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.561484e-01 | 0.255 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.563563e-01 | 0.255 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.657554e-01 | 0.247 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.657554e-01 | 0.247 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.657554e-01 | 0.247 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.657554e-01 | 0.247 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.673185e-01 | 0.246 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.733725e-01 | 0.242 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.749558e-01 | 0.240 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.749558e-01 | 0.240 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.749558e-01 | 0.240 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.749558e-01 | 0.240 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 5.749558e-01 | 0.240 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.749558e-01 | 0.240 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 5.805108e-01 | 0.236 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.839620e-01 | 0.234 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.839620e-01 | 0.234 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.839620e-01 | 0.234 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.839620e-01 | 0.234 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.839620e-01 | 0.234 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.839620e-01 | 0.234 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.839620e-01 | 0.234 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.839620e-01 | 0.234 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.839620e-01 | 0.234 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.839620e-01 | 0.234 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.911637e-01 | 0.228 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.911637e-01 | 0.228 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.914570e-01 | 0.228 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.927778e-01 | 0.227 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 5.927778e-01 | 0.227 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.927778e-01 | 0.227 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.969704e-01 | 0.224 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.969704e-01 | 0.224 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.993840e-01 | 0.222 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.014073e-01 | 0.221 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.014073e-01 | 0.221 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.014073e-01 | 0.221 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.014073e-01 | 0.221 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.014073e-01 | 0.221 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.014073e-01 | 0.221 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.014073e-01 | 0.221 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.027151e-01 | 0.220 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.027151e-01 | 0.220 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.046887e-01 | 0.218 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.083978e-01 | 0.216 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.098545e-01 | 0.215 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.154151e-01 | 0.211 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.181232e-01 | 0.209 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 6.181232e-01 | 0.209 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.227125e-01 | 0.206 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.227125e-01 | 0.206 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.250752e-01 | 0.204 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.250752e-01 | 0.204 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.262172e-01 | 0.203 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.262172e-01 | 0.203 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.262172e-01 | 0.203 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.262172e-01 | 0.203 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.262172e-01 | 0.203 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.262172e-01 | 0.203 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.262172e-01 | 0.203 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.341400e-01 | 0.198 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.341400e-01 | 0.198 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.341400e-01 | 0.198 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.341400e-01 | 0.198 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.341400e-01 | 0.198 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.341400e-01 | 0.198 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.341400e-01 | 0.198 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.341400e-01 | 0.198 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.358852e-01 | 0.197 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.411982e-01 | 0.193 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.411982e-01 | 0.193 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.418955e-01 | 0.193 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.418955e-01 | 0.193 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.418955e-01 | 0.193 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.418955e-01 | 0.193 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.464501e-01 | 0.189 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.494869e-01 | 0.187 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.494869e-01 | 0.187 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.494869e-01 | 0.187 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.525887e-01 | 0.185 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.525887e-01 | 0.185 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.525887e-01 | 0.185 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.569180e-01 | 0.182 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.569180e-01 | 0.182 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.569180e-01 | 0.182 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.641919e-01 | 0.178 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.641919e-01 | 0.178 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.650743e-01 | 0.177 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.650743e-01 | 0.177 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.713120e-01 | 0.173 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.713120e-01 | 0.173 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.713120e-01 | 0.173 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.713120e-01 | 0.173 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.732156e-01 | 0.172 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.754363e-01 | 0.170 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.766906e-01 | 0.170 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.782816e-01 | 0.169 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.782816e-01 | 0.169 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.782816e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.782816e-01 | 0.169 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 6.782816e-01 | 0.169 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.851039e-01 | 0.164 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.851039e-01 | 0.164 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.851039e-01 | 0.164 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.851039e-01 | 0.164 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.851039e-01 | 0.164 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.851039e-01 | 0.164 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.851039e-01 | 0.164 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.851039e-01 | 0.164 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.851039e-01 | 0.164 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.862931e-01 | 0.163 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.983186e-01 | 0.156 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.983186e-01 | 0.156 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.983186e-01 | 0.156 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.037931e-01 | 0.153 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.047171e-01 | 0.152 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 7.047171e-01 | 0.152 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.080492e-01 | 0.150 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.109803e-01 | 0.148 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 7.142643e-01 | 0.146 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.171111e-01 | 0.144 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.171111e-01 | 0.144 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.223839e-01 | 0.141 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.231121e-01 | 0.141 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.289862e-01 | 0.137 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.289862e-01 | 0.137 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.311409e-01 | 0.136 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.347361e-01 | 0.134 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.403643e-01 | 0.131 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.403643e-01 | 0.131 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.431191e-01 | 0.129 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.458734e-01 | 0.127 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.458734e-01 | 0.127 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.458734e-01 | 0.127 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.458734e-01 | 0.127 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.510355e-01 | 0.124 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.512660e-01 | 0.124 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.565445e-01 | 0.121 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.617112e-01 | 0.118 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.617112e-01 | 0.118 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.617112e-01 | 0.118 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.617112e-01 | 0.118 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.617112e-01 | 0.118 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.625169e-01 | 0.118 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.667686e-01 | 0.115 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 7.667686e-01 | 0.115 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.667686e-01 | 0.115 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.690689e-01 | 0.114 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.717190e-01 | 0.113 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.717190e-01 | 0.113 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.717190e-01 | 0.113 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.717190e-01 | 0.113 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.717190e-01 | 0.113 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.759497e-01 | 0.110 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.765647e-01 | 0.110 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.765647e-01 | 0.110 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.765647e-01 | 0.110 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.781604e-01 | 0.109 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.781604e-01 | 0.109 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.806345e-01 | 0.108 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.813077e-01 | 0.107 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.859504e-01 | 0.105 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.859504e-01 | 0.105 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.904947e-01 | 0.102 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.949429e-01 | 0.100 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.992969e-01 | 0.097 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.007698e-01 | 0.096 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.007698e-01 | 0.096 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.007698e-01 | 0.096 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 8.035587e-01 | 0.095 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.118135e-01 | 0.091 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.118135e-01 | 0.091 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.158103e-01 | 0.088 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.158103e-01 | 0.088 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 8.158103e-01 | 0.088 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.192520e-01 | 0.087 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.197224e-01 | 0.086 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.197224e-01 | 0.086 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.250635e-01 | 0.084 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.281211e-01 | 0.082 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.286508e-01 | 0.082 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.309686e-01 | 0.080 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.309686e-01 | 0.080 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.388653e-01 | 0.076 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.466668e-01 | 0.072 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.481791e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.481791e-01 | 0.072 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.481791e-01 | 0.072 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.514055e-01 | 0.070 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.514055e-01 | 0.070 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 8.537746e-01 | 0.069 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.693777e-01 | 0.061 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 8.693777e-01 | 0.061 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.693777e-01 | 0.061 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.721548e-01 | 0.059 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.826869e-01 | 0.054 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.827645e-01 | 0.054 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.885923e-01 | 0.051 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.900140e-01 | 0.051 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.923536e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.990786e-01 | 0.046 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.990786e-01 | 0.046 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.990786e-01 | 0.046 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.995383e-01 | 0.046 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.012258e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.033275e-01 | 0.044 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.053846e-01 | 0.043 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.112977e-01 | 0.040 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.112977e-01 | 0.040 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.127490e-01 | 0.040 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.168423e-01 | 0.038 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.168423e-01 | 0.038 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.168423e-01 | 0.038 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.203453e-01 | 0.036 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.237011e-01 | 0.034 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.237799e-01 | 0.034 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.269160e-01 | 0.033 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.357696e-01 | 0.029 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.371408e-01 | 0.028 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.371695e-01 | 0.028 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.397908e-01 | 0.027 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.415729e-01 | 0.026 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.447613e-01 | 0.025 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.447962e-01 | 0.025 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.470909e-01 | 0.024 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.470909e-01 | 0.024 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.470909e-01 | 0.024 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.503933e-01 | 0.022 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.573490e-01 | 0.019 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.573490e-01 | 0.019 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.573490e-01 | 0.019 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.625252e-01 | 0.017 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.632660e-01 | 0.016 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.633248e-01 | 0.016 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.699255e-01 | 0.013 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.710733e-01 | 0.013 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.725534e-01 | 0.012 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.728872e-01 | 0.012 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.735415e-01 | 0.012 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.745876e-01 | 0.011 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.753253e-01 | 0.011 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.756617e-01 | 0.011 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.763006e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.766905e-01 | 0.010 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.791761e-01 | 0.009 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.806423e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.812195e-01 | 0.008 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.819222e-01 | 0.008 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.831433e-01 | 0.007 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.842412e-01 | 0.007 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.872745e-01 | 0.006 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.878135e-01 | 0.005 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.889420e-01 | 0.005 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.911924e-01 | 0.004 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.913065e-01 | 0.004 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.938723e-01 | 0.003 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.962194e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.988816e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.993394e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.994058e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.998743e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999927e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999983e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |